1-14 of 14
Peter Barth
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Ibrutinib in Combination with Revlimid/Dexamethasone (Rd) in Relapsed/Refractory Multiple Myeloma (AFT-15)

Yvonne Efebera, Vera Jean Suman, Shira N. Dinner, Ashley E Rosko, John T Mckay, Peter Barth, Patrick Hagen, Saad Z Usmani, Paul G. Richardson, Jacob P. Laubach
Journal: Blood
Blood (2023) 142 (Supplement 1): 3340.
https://doi.org/10.1182/blood-2023-187296
Published: 2023
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Omar Nadeem, Robert A. Redd, Trevor J. Bayliss, Peter Barth, Jacob Laubach, Clifton C. Mo, Giada Bianchi, Kelly Masone, Kyle Griffin, Lindsay Issokson, Anna Barrell, Randi Doherty, Deborah Mailand, Alexandra Distaso, Sarah Patches, Kathryn Goodrich, Kathleen Oneill, Vaishali Sanchorawala, Leyla O. Shune, Paul G. Richardson
Journal: Blood
Blood (2022) 140 (Supplement 1): 10180–10181.
https://doi.org/10.1182/blood-2022-165512
Published: 2022
Journal Articles

Factors Associated with Seroconversion after COVID-19 Vaccination in Patients with Hematologic Malignancies

Thomas A. Ollila, Rebecca Masel, John L Reagan, Kimberly Paiva, Shaolei Lu, Ralph Rogers, Adam Zayac, Rashida Taher, Inna Yakirevich, Rabin Niroula, Peter Barth, Adam J. Olszewski
Journal: Blood
Blood (2021) 138 (Supplement 1): 3511.
https://doi.org/10.1182/blood-2021-144304
Published: 2021
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma

Omar Nadeem, Robert A. Redd, Peter Barth, Clifton C Mo, Jacob P. Laubach, Giada Bianchi, Trevor J. Bayliss, Vaishali Sanchorawala, Leyla Shune, Alexandra Distaso, Virginia Dalton, Mary McKenney, Sarah Patches, Isabella Hou, Lindsay Issokson, Anna Barrell, Kelly Masone, Adam S. Sperling, Nikhil C. Munshi, Irene M. Ghobrial, Kenneth C. Anderson, Paul G. Richardson
Journal: Blood
Blood (2021) 138 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2021-146866
Published: 2021
Journal Articles

Safety Profile of Maintenance Obinutuzumab in Patients with Primary CNS Lymphoma in Complete Response

Nancy D. Doolittle, Prakash Ambady, David M. Peereboom, Douglas E. Ney, Larry Junck, Yoshie Umemura, Roy Ervin Strowd III, Glenn J. Lesser, David Schiff, Camilo E. Fadul, Michael Glantz, MD PhD, Erin M. Dunbar, Peter Barth, Edward Pan, Alissa A. Thomas, Rongwei Fu, Edward A. Neuwelt
Journal: Blood
Blood (2020) 136 (Supplement 1): 12.
https://doi.org/10.1182/blood-2020-134457
Published: 2020
Journal Articles

A Phase I/II Study of Twice Weekly Ixazomib Plus Pomalidomide and Dexamethasone in Relapsed and Refractory Multiple Myeloma: Results from Phase I Dose Escalation Cohorts

Omar Nadeem, MD, Clifton C Mo, MD, Jacob P. Laubach, MD, Giada Bianchi, MD, Robert Redd, Peter Barth, Trevor J. Bayliss, MD, Vaishali Sanchorawala, MD, Leyla Shune, MD, Alexandra Distaso, Virginia Dalton, MS, APRN, Adam S Sperling, MD PhD, Laura Amweg, Mary McKenney, NP, Kathleen Colson, BS,BSN,RN, Ella L Millard, Isabella Hou, Alexandra Savell, BS, Kelly Masone, BA, Nikhil C. Munshi, MD, Irene M. Ghobrial, MD, Kenneth Anderson, MD, Paul G. Richardson, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 1–2.
https://doi.org/10.1182/blood-2020-141549
Published: 2020
Journal Articles

Comparative Effectiveness of Lenalidomide, Bortezomib, and Their Combinations As First-Line Treatment of Older Patients with Myeloma

Peter Barth, MD, Smith Giri, MBBS, John L. Reagan, MD, Adam J Olszewski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3155.
https://doi.org/10.1182/blood-2019-121992
Published: 2019
Journal Articles

BrUOG 345: Fractionated Gemtuzumab Ozogamicin Followed By Non-Engraftment Donor Leukocyte Infusions for Relapsed/Refractory Acute Myeloid Leukemia

Adam Zayac, MD, Pamela C Egan, MD, Thomas A Ollila, MD, Adam J Olszewski, MD, Peter Barth, MD, Matthew I. Quesenberry, MD, James Butera, MD, Loren D. Fast, PhD, Rabin Niroula, MBBS, Peter J. Quesenberry, MD, John L Reagan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4460.
https://doi.org/10.1182/blood-2019-123789
Published: 2019
Journal Articles

Second Primary Malignancy Among Patients with Plasma Cell Myeloma Receiving First-Line Lenalidomide-Based Therapy: A Population-Based Analysis

Smith Giri, MBBS, Peter Barth, MD, Luciano J. Costa, MD PhD, Adam J Olszewski, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1862.
https://doi.org/10.1182/blood-2019-131231
Published: 2019
Journal Articles

Evaluating the Incidence of Cardiovascular and Thrombotic Events in Secondary Polycythemia

Clara Mao, BS, Adam J Olszewski, MD, Pamela C Egan, MD, Peter Barth, MD, John L Reagan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3511.
https://doi.org/10.1182/blood-2019-122943
Published: 2019
Journal Articles

Use of Bone-Modifying Agents and Outcomes of Myeloma Therapy: A Population-Based Study

Adam J Olszewski, MD, Peter Barth, MD, John L. Reagan, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 709.
https://doi.org/10.1182/blood-2018-99-110739
Published: 2018
Journal Articles

Prognosis after Upfront Radiation Therapy in Plasma Cell Myeloma: Analysis of the National Cancer Data Base

Xavier Orcutt, BA, Peter Barth, MD, Adam J Olszewski, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 3230.
https://doi.org/10.1182/blood-2018-99-110108
Published: 2018
Journal Articles

Single-Center Experience of the Utility of a Rapid ADAMTS13 Assay

Peter Barth, MD, Ari Pelcovits, MD, John L Reagan, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 3630.
https://doi.org/10.1182/blood.V130.Suppl_1.3630.3630
Published: 2017
Journal Articles

Detection of Significantly Increased Frequencies of Proteinase-3 (Myeloblastin) - Specific CD8+ T-Cells in Patients with De Novo Diagnosed Hepatitis C and Infiltration of Liver Tissue with Proteinase 3 Overexpressing Mononuclear Cells.

Andreas Burchert, MD, Thomas Berg, MD, Markus Ritter, MD, Peter Barth, MD, Andreas Neubauer, MD
Journal: Blood
Blood (2004) 104 (11): 3867.
https://doi.org/10.1182/blood.V104.11.3867.3867
Published: 2004